BioSpace News Archive

Across the Pharm Country Hotbed, the agency has provided hundreds of millions of dollars to universities, research institutes and pharmaceutical companies.

Century Therapeutics received a $160 million infusion of cash to advance the company’s pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies for cancer.

ASLAN Pharmaceuticals, a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced the pricing of an underwritten public offering of 15,000,000 American Depositary Shares representing 75,000,000 ordinary shares at a price to the public of $4.00 per ADS.

Sheldon Moberg joins Bexson as Senior VP Drug Delivery, where he’ll lead the development of proprietary devices that can make controlled substances and other therapies more accessible.

Peer-reviewed article confirms the quality and robustness of clinical data and the good safety and durable efficacy of once daily oral ABX464 in moderate to severe ulcerative colitis (UC) patients Recruitment of subsequent phase 2b induction study in 254 patients with ABX464 in UC completed in December 2020 and top-line results are expected in Q2 2021 Abivax is preparing to move its lead drug-candidate ABX464 into a phase 3 clinical program in ulcerative colitis and to initiate a phase

AnteoTech’s long-term customer Ellume, producer of next-generation digitally enabled diagnostic solutions, has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test.

Harrington Discovery Institute at University Hospitals and the Alzheimer’s Drug Discovery Foundation (ADDF) announce a joint request for proposals for the 2021 ADDF-Harrington Scholar Award .

Mitsubishi Tanabe Pharma America, Inc. announced that Mitsubishi Tanabe Pharma Holdings America, Inc. plans to establish a new NeuroDiscovery Lab in the U.S. biotechnology hub of Cambridge, Mass.

A detailed analysis of mental health treatment trends during the COVID-19 pandemic found a 7% increase in visits during the initial shelter-in-place period in 2020, compared with the same 3-month period in 2019.

Devastated by the loss of her husband Kenneth Bruntel to pancreatic cancer, Gail Coleman is laser-focused on funding research offering hope and better treatment options for patients with metastatic cancer.